| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
BIRC2 |
BIRC2, API1, IAP2, MIHB, RNF48: Baculoviral IAP repeat-containing protein 2 |
11.730 |
Evidence |
|
| CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
SCML2 |
SCML2: Sex comb on midleg-like protein 2 |
11.700 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
11.700 |
Evidence |
|
| ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
HAVCR1 |
HAVCR1, TIM1, TIMD1: Hepatitis A virus cellular receptor 1 precursor |
11.700 |
Evidence |
|
| S100A7 |
S100A7, PSOR1: Protein S100-A7 |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
11.700 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
11.700 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
11.700 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
PTPRG |
PTPRG, PTPG: Receptor-type tyrosine-protein phosphatase gamma precursor |
11.700 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
PTPRG |
PTPRG, PTPG: Receptor-type tyrosine-protein phosphatase gamma precursor |
11.700 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
PTPRG |
PTPRG, PTPG: Receptor-type tyrosine-protein phosphatase gamma precursor |
11.700 |
Evidence |
|
| F8 |
F8, F8C: Coagulation factor VIII precursor |
F5 |
F5: Coagulation factor V precursor |
11.700 |
Evidence |
|
| SNCG |
SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
11.700 |
Evidence |
|
| RPL4 |
RPL4, RPL1: 60S ribosomal protein L4 |
RPL8 |
RPL8: 60S ribosomal protein L8 |
11.680 |
Evidence |
|
| LAMR1 |
RPSA, LAMBR, LAMR1: 40S ribosomal protein SA |
RPL4 |
RPL4, RPL1: 60S ribosomal protein L4 |
11.680 |
Evidence |
|
| DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
11.660 |
Evidence |
|
| HNRPD |
HNRPD, AUF1: Heterogeneous nuclear ribonucleoprotein D0 |
PCBP2 |
PCBP2: Poly(rC)-binding protein 2 |
11.660 |
Evidence |
|
| CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
SH3KBP1 |
SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 |
11.660 |
Evidence |
|
| TIAM1 |
TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
11.660 |
Evidence |
|
| GRIK2 |
GRIK2, GLUR6: Glutamate receptor, ionotropic kainate 2 precursor |
PRKACA |
PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit |
11.660 |
Evidence |
|
| GRIK2 |
GRIK2, GLUR6: Glutamate receptor, ionotropic kainate 2 precursor |
AKT3 |
AKT3: RAC-gamma serine/threonine-protein kinase |
11.660 |
Evidence |
|
| GRIN1 |
GRIN1, NMDAR1: Glutamate [NMDA] receptor subunit zeta-1 precursor |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
11.660 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
11.660 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
11.660 |
Evidence |
|
| SPTBN1 |
SPTBN1, SPTB2: Spectrin beta chain, brain 1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
11.660 |
Evidence |
|
| TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
11.660 |
Evidence |
|